Three independent isolates were shown to produce a new anti-MRSA bioactive compound that was
OPEN ACCESS
Mar. Drugs 2013, 11 1072
identified as kocurin, a new member of the thiazolyl peptide family of antibiotics emphasizing the role of this family as a prolific resource for novel drugs.